• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风湿性疾病患儿和青少年中 annexin A5 耐药的流行情况。

Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases.

机构信息

Children's Hospital at Montefiore, Department of Pediatrics, Division of Rheumatology, Bronx, NY 10467, USA.

出版信息

J Rheumatol. 2012 Feb;39(2):382-8. doi: 10.3899/jrheum.110768. Epub 2011 Dec 15.

DOI:10.3899/jrheum.110768
PMID:22174207
Abstract

OBJECTIVE

The underlying mechanism(s) by which antiphospholipid antibodies (aPL) result in thrombosis remains poorly understood. A significant body of evidence has evolved to support the hypothesis that antibody-mediated disruption of an annexin A5 anticoagulant shield may play a role in the pathogenesis; this proposed mechanism has not been previously studied in children.

METHODS

We investigated the association between aPL and resistance to annexin A5 anticoagulant activity in 90 children with a variety of rheumatic diseases using a novel mechanistic assay, the annexin A5 resistance assay (A5R).

RESULTS

Patients with a diagnosis of primary aPL syndrome, systemic lupus erythematosus, and mixed connective tissue disease demonstrated lower mean A5R levels (p = 0.030), higher prevalence of positive aPL (p < 0.001), and more thrombotic events (p = 0.014) compared to those with other diagnoses. Patients with persistently positive aPL had significantly lower mean A5R compared to patients with no aPL (mean A5R = 203% ± 44% vs 247% ± 35%; p < 0.001), whereas patients with transient aPL did not. Patients with thrombosis had lower A5R levels compared to those without thrombosis (mean A5R = 207% ± 36% vs 237% ± 46%; p = 0.048).

CONCLUSION

Children and adolescents with rheumatic diseases and persistent aPL have reduced annexin A5 anticoagulant activity, whereas transient, nonpathogenic aPL have less effect on annexin A5 activity.

摘要

目的

抗磷脂抗体 (aPL) 导致血栓形成的潜在机制仍知之甚少。大量证据支持抗体介导的破坏 annexin A5 抗凝屏蔽可能在发病机制中起作用的假说;这一提出的机制以前尚未在儿童中进行过研究。

方法

我们使用一种新的机制性测定法,即 annexin A5 抵抗测定法 (A5R),研究了 90 名患有各种风湿性疾病的儿童中 aPL 与 annexin A5 抗凝活性抵抗之间的关联。

结果

与其他诊断相比,原发性 aPL 综合征、系统性红斑狼疮和混合性结缔组织病患者的平均 A5R 水平较低(p = 0.030),aPL 阳性率较高(p < 0.001),血栓事件更多(p = 0.014)。与无 aPL 的患者相比,持续存在 aPL 的患者的平均 A5R 明显较低(平均 A5R = 203% ± 44%比 247% ± 35%;p < 0.001),而一过性 aPL 的患者则不然。与无血栓形成的患者相比,发生血栓形成的患者的 A5R 水平较低(平均 A5R = 207% ± 36%比 237% ± 46%;p = 0.048)。

结论

患有风湿性疾病和持续性 aPL 的儿童和青少年 annexin A5 抗凝活性降低,而短暂性、非致病性 aPL 对 annexin A5 活性的影响较小。

相似文献

1
Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases.风湿性疾病患儿和青少年中 annexin A5 耐药的流行情况。
J Rheumatol. 2012 Feb;39(2):382-8. doi: 10.3899/jrheum.110768. Epub 2011 Dec 15.
2
Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.降低 annexin A5 抗凝比率可识别出具有不良临床结局的抗磷脂抗体阳性患者。
J Thromb Haemost. 2017 Jul;15(7):1412-1421. doi: 10.1111/jth.13699. Epub 2017 Jun 12.
3
Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.抗凝血素 A5 活性在系统性红斑狼疮患儿中的变化及其与抗β2-糖蛋白 I 域 I 抗体的相关性。
Lupus. 2013 Jun;22(7):702-11. doi: 10.1177/0961203313490241. Epub 2013 May 20.
4
Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome. Annexin-A5 耐药性和非标准抗体用于诊断血清阴性抗磷脂综合征。
Clin Rheumatol. 2020 Apr;39(4):1167-1171. doi: 10.1007/s10067-019-04915-5. Epub 2020 Jan 10.
5
Association of silent infarcts in sickle cell anemia with decreased annexin A5 resistance.镰状细胞贫血症中无症状性梗死与膜联蛋白A5抗性降低的关联。
Blood Cells Mol Dis. 2018 Mar;69:53-56. doi: 10.1016/j.bcmd.2017.09.001. Epub 2017 Sep 4.
6
Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.患有风湿性疾病的儿童和成人患者体内的抗磷脂抗体与细小病毒B19感染有关。
Arthritis Rheum. 2003 Jul;48(7):1939-47. doi: 10.1002/art.11038.
7
Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.膜联蛋白A5基因多态性(-1C→T)与抗磷脂综合征中抗膜联蛋白A5抗体的存在
Ann Rheum Dis. 2006 Nov;65(11):1468-72. doi: 10.1136/ard.2005.045237. Epub 2006 Jan 31.
8
Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.人源单克隆抗磷脂抗体破坏磷脂双分子层上的膜联蛋白A5抗凝晶体屏障:来自原子力显微镜和功能测定的证据。
Am J Pathol. 2003 Sep;163(3):1193-200. doi: 10.1016/S0002-9440(10)63479-7.
9
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.系统性红斑狼疮和抗磷脂抗体患者的抗磷脂综合征肾病:患病率、临床关联及长期预后
Arthritis Rheum. 2004 Aug;50(8):2569-79. doi: 10.1002/art.20433.
10
Detection of complement-fixing antiphospholipid antibodies in association with thrombosis.与血栓形成相关的补体结合抗磷脂抗体的检测
Thromb Haemost. 2000 May;83(5):728-31.

引用本文的文献

1
Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.抗凝血素 A5 活性在系统性红斑狼疮患儿中的变化及其与抗β2-糖蛋白 I 域 I 抗体的相关性。
Lupus. 2013 Jun;22(7):702-11. doi: 10.1177/0961203313490241. Epub 2013 May 20.